Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
Conditions: Melanoma; Hodgkin Lymphoma; Non Small Cell Lung Cancer Intervention: Sponsor: University of Cologne Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Lymphoma | Melanoma | Meningitis Vaccine | Pneomococcal Vaccine | Research | Skin Cancer | Vaccines